Heparin medicine for early slow fetal growth in one pregnancy
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study tests whether a blood-thinner medicine (LMWH) can improve outcomes for people carrying a singleton baby with early signs of slow growth. It compares LMWH against standard care to see if treatment helps the baby and pregnancy stay safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and can give consent
- You are pregnant with one baby (not twins or more)
- Your early baby-growth problem was confirmed at the study site using ultrasound criteria
- You are not already taking LMWH or the related blood thinner for this pregnancy
- You do not have certain bleeding risks or bleeding conditions right now
- You likely will not deliver in the next 7 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at two ways to manage early-onset fetal growth restriction (when a baby is smaller than expected). It compares using blood tests for angiogenic factors versus feto-placental Doppler ultrasound to guide care. The goal is to find the best way to monitor and protect your baby's health.
This study looks at therapies meant to support brain development in babies whose growth is slower than expected before birth. It enrolls pregnancies in a specific time window and uses ultrasound/Doppler testing to make sure the baby is not likely needing delivery immediately.
This trial studies whether taking melatonin during pregnancy can help protect the baby’s brain and organs in cases of poor fetal growth. It focuses on pregnancies at a specific gestational age with signs that the placenta may not be working well.
This study tests whether a blood thinner called enoxaparin can improve outcomes for babies who are growing slowly in the womb (intrauterine growth restriction, or IUGR) and who have low amniotic fluid. If you qualify, you may receive enoxaparin injections to see if it helps your baby grow better and reduces risks.
This study looks at how people’s blood and clotting behave during pregnancy when taking a specific blood thinner called low molecular weight heparin (LMWH) three times a day. It may help doctors fine-tune how safely and effectively LMWH is used during pregnancy.
This trial tests whether a blood-thinning medication (enoxaparin) can help prevent complications like preterm birth or preeclampsia from happening again. It is for people who had a past pregnancy problem tied to placenta blood flow issues.
Hear when a new Fetal Growth Retardation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.